We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+9.09%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$18.6B
AUM Growth
+$370M
(+2%)
Cap. Flow
-$1.05B
Cap. Flow
% of AUM
-5.64%
Top 10 Holdings %
Top 10 Hldgs %
19.87%
Holding
1,286
New
95
Increased
394
Reduced
580
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$42.1M |
| 2 |
Amazon
AMZN
|
+$37.3M |
| 3 |
Agilent Technologies
A
|
+$34.9M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$34.7M |
| 5 |
Netflix
NFLX
|
+$33.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$132M |
| 2 |
Cencora
COR
|
+$65.6M |
| 3 |
Biogen
BIIB
|
+$53.3M |
| 4 |
Applied Materials
AMAT
|
+$44.9M |
| 5 |
Dollar General
DG
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.39% |
| 2 | Healthcare | 13.06% |
| 3 | Financials | 11.34% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCYC
976
Bicycle Therapeutics
BCYC
$275M
| $295K | ﹤0.01% |
+9,908
| New | +$256K |
|
977
NVR
NVR
$17.3B
| $295K | ﹤0.01% |
63
-205
| -76% | -$920K |
|
978
Honda
HMC
$39.3B
| $292K | ﹤0.01% |
9,705
-33,651
| -78% | -$968K |
|
979
Pinnacle Financial Partners Inc
PNFP
$15.9B
| $290K | ﹤0.01% |
3,287
-1,224
| -27% | -$96.8K |
|
980
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$220M
| $290K | ﹤0.01% |
5,541
| – | – |
|
|
LSXMK
981
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $290K | ﹤0.01% |
8,530
| – | – |
|
982
Western Union
WU
$2.58B
| $285K | ﹤0.01% |
11,656
-26,384
| -69% | -$621K |
|
983
Cullen/Frost Bankers
CFR
$10.5B
| $282K | ﹤0.01% |
2,600
| – | – |
|
984
HSBC
HSBC
$356B
| $282K | ﹤0.01% |
9,718
-210
| -2% | -$6K |
|
985
Interparfums
IPAR
$4.09B
| $281K | ﹤0.01% |
3,966
-2,162
| -35% | -$147K |
|
986
Vale
VALE
$62.6B
| $280K | ﹤0.01% |
16,141
+18
| +0.1% | +$314 |
|
987
Vanguard Energy ETF
VDE
$9.72B
| $280K | ﹤0.01% |
4,124
+3,354
| +436% | +$214K |
|
|
NKLA
988
DELISTED
Nikola Corporation Common Stock
NKLA
| $277K | ﹤0.01% |
667
+334
| +100% | +$190K |
|
989
Invesco Dorsey Wright Industrials Momentum ETF
PRN
$405M
| $274K | ﹤0.01% |
2,686
| – | – |
|
990
Unifirst Corp
UNF
$5.43B
| $274K | ﹤0.01% |
1,227
-276
| -18% | -$63.6K |
|
991
HCA Healthcare
HCA
$92.8B
| $272K | ﹤0.01% |
+1,447
| New | +$255K |
|
992
Central Garden & Pet Co
CENT
$2.78B
| $271K | ﹤0.01% |
5,844
-482
| -8% | -$18.2K |
|
993
J&J Snack Foods
JJSF
$1.49B
| $271K | ﹤0.01% |
1,727
-56
| -3% | -$8.79K |
|
994
Q2 Holdings
QTWO
$3.71B
| $271K | ﹤0.01% |
2,705
+80
| +3% | +$9.95K |
|
|
CGC
995
Canopy Growth
CGC
$377M
| $270K | ﹤0.01% |
846
-8
| -0.9% | -$2.83K |
|
996
Cooper Companies
COO
$14.1B
| $270K | ﹤0.01% |
2,816
-180
| -6% | -$17.1K |
|
997
RH
RH
$3.36B
| $270K | ﹤0.01% |
453
-1,560
| -77% | -$769K |
|
998
Spotify
SPOT
$105B
| $270K | ﹤0.01% |
+1,011
| New | +$315K |
|
999
VeriSign
VRSN
$25.4B
| $270K | ﹤0.01% |
1,360
-3
| -0.2% | -$589 |
|
1000
Integra LifeSciences
IART
$1.54B
| $268K | ﹤0.01% |
3,889
-1,766
| -31% | -$120K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2021 Portfolio in Review
As of Q1 2021, Glenmede Trust held 1,286 positions worth $18.6B, up 2% from $18.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Glenmede Trust withdrew a net $1.05B in Q1 2021, closing 90 positions and reducing 580 holdings. Its most notable exit was Coherent, an estimated $32.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Glenmede Trust opened a new position in Rollins worth $29.6M.
- Glenmede Trust's largest Q1 2021 buy was Rollins: 860,755 shares worth $29.6M.
- Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $42.1M increase.
- Glenmede Trust's biggest Q1 2021 reduction was Progressive, cutting an estimated $132M.
- Glenmede Trust fully exited Coherent in Q1 2021, selling an estimated $32.9M.
- Glenmede Trust's ten largest holdings make up 20% of its $18.6B portfolio in Q1 2021.
- Glenmede Trust opened 95 new positions and closed 90 in Q1 2021.
- Glenmede Trust's portfolio value rose 2% quarter-over-quarter to $18.6B.
Based on Glenmede Trust's 13F filing for Q1 2021, filed 18 May 2021.